News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Seidel-Dugan Cynthia
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/09/2023 |
4
| Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 115,900 options to buy
@ $2.05, valued at
$237.6k
|
|
| 01/14/2022 |
4
| Seidel-Dugan Cynthia (Chief Scientific Officer) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Granted 79,516 options to buy
@ $11.55, valued at
$918.4k
Exercised 24,199 options to buy
@ $1.56, valued at
$37.8k
Exercised 15,532 options to buy
@ $4.77, valued at
$74.1k
|
|
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|